• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为CB1大麻素受体配体的取代5,5'-二苯基-2-硫代咪唑啉-4-酮:合成与药理学评价

Substituted 5,5'-diphenyl-2-thioxoimidazolidin-4-one as CB1 cannabinoid receptor ligands: synthesis and pharmacological evaluation.

作者信息

Muccioli Giulio G, Martin Diana, Scriba Gerhard K E, Poppitz Wolfgang, Poupaert Jacques H, Wouters Johan, Lambert Didier M

机构信息

Unité de Chimie Pharmaceutique et de Radiopharmacie, Ecole de Pharmacie, Faculté de Médecine, Université catholique de Louvain, Avenue E. Mounier 73, UCL-CMFA 7340, B-1200 Bruxelles, Belgium.

出版信息

J Med Chem. 2005 Apr 7;48(7):2509-17. doi: 10.1021/jm049263k.

DOI:10.1021/jm049263k
PMID:15801840
Abstract

A set of 30 substituted 5,5'-diphenyl-2-thioxoimidazolidin-4-one (thiohydantoins) derivatives was synthesized, and their affinity for the human CB(1) cannabinoid receptor has been evaluated. These compounds are derived from the previously described cannabinoid ligands 5,5'-diphenylimidazolidine-2,4-dione (hydantoins). The replacement of the oxygen by a sulfur leads to an increase of the affinity while the function-i.e., inverse agonism-determined by [(35)S]GTPgammaS experiments remains unaffected. Finally, to evaluate the molecular parameters that could influence the affinity of the thiohydantoins, molecular electrostatic potential as well as lipophilicity calculations were undertaken on representative thiohydantoins and hydantoins derivatives. In conclusion, 5,5'-bis-(4-iodophenyl)-3-butyl-2-thioxoimidazolidin-4-one (31) and 3-allyl-5,5'-bis(4-bromophenyl)-2-thioxoimidazolidin-4-one (32) possess the highest affinity for the CB(1) cannabinoid receptor described to date for the hydantoin and thiohydantoins series when compared in a same bioassay.

摘要

合成了一组30种取代的5,5'-二苯基-2-硫代氧代咪唑烷-4-酮(硫代乙内酰脲)衍生物,并评估了它们对人CB(1)大麻素受体的亲和力。这些化合物衍生自先前描述的大麻素配体5,5'-二苯基咪唑烷-2,4-二酮(乙内酰脲)。用硫取代氧会导致亲和力增加,而通过[(35)S]GTPγS实验确定的功能(即反向激动作用)不受影响。最后,为了评估可能影响硫代乙内酰脲亲和力的分子参数,对代表性的硫代乙内酰脲和乙内酰脲衍生物进行了分子静电势以及亲脂性计算。总之,在相同生物测定中比较时,5,5'-双-(4-碘苯基)-3-丁基-2-硫代氧代咪唑烷-4-酮(31)和3-烯丙基-5,5'-双(4-溴苯基)-2-硫代氧代咪唑烷-4-酮(32)对CB(1)大麻素受体具有迄今为止乙内酰脲和硫代乙内酰脲系列中描述的最高亲和力。

相似文献

1
Substituted 5,5'-diphenyl-2-thioxoimidazolidin-4-one as CB1 cannabinoid receptor ligands: synthesis and pharmacological evaluation.作为CB1大麻素受体配体的取代5,5'-二苯基-2-硫代咪唑啉-4-酮:合成与药理学评价
J Med Chem. 2005 Apr 7;48(7):2509-17. doi: 10.1021/jm049263k.
2
Synthesis and activity of 1,3,5-triphenylimidazolidine-2,4-diones and 1,3,5-triphenyl-2-thioxoimidazolidin-4-ones: characterization of new CB1 cannabinoid receptor inverse agonists/antagonists.1,3,5-三苯基咪唑烷-2,4-二酮和1,3,5-三苯基-2-硫代咪唑烷-4-酮的合成与活性:新型CB1大麻素受体反向激动剂/拮抗剂的表征
J Med Chem. 2006 Feb 9;49(3):872-82. doi: 10.1021/jm050484f.
3
Substituted 2-thioxoimidazolidin-4-ones and imidazolidine-2,4-diones as fatty acid amide hydrolase inhibitors templates.作为脂肪酸酰胺水解酶抑制剂模板的取代2-硫代咪唑烷-4-酮和咪唑烷-2,4-二酮
J Med Chem. 2006 Jan 12;49(1):417-25. doi: 10.1021/jm050977k.
4
1-Benzhydryl-3-phenylurea and 1-benzhydryl-3-phenylthiourea derivatives: new templates among the CB1 cannabinoid receptor inverse agonists.1-二苯甲基-3-苯基脲和1-二苯甲基-3-苯基硫脲衍生物:CB1大麻素受体反向激动剂中的新型模板
J Med Chem. 2005 Nov 17;48(23):7486-90. doi: 10.1021/jm0503906.
5
Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB1 and CB2 receptors.咪唑烷二酮衍生物在大麻素CB1和CB2受体上的药理学特性
Eur J Pharmacol. 2004 Jul 8;495(1):43-53. doi: 10.1016/j.ejphar.2004.05.023.
6
Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor.LH-21的药理学评估,LH-21是一种新发现的与大麻素CB1受体结合的分子。
Eur J Pharmacol. 2008 Apr 28;584(2-3):338-42. doi: 10.1016/j.ejphar.2008.02.029. Epub 2008 Feb 19.
7
Oxadiazole-diarylpyrazole 4-carboxamides as cannabinoid CB1 receptor ligands.作为大麻素CB1受体配体的恶二唑-二芳基吡唑4-甲酰胺
Bioorg Med Chem Lett. 2009 Apr 1;19(7):1899-902. doi: 10.1016/j.bmcl.2009.02.063. Epub 2009 Feb 21.
8
Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.香豆素衍生物作为大麻素受体拮抗剂和反向激动剂的合成及药理学评价
Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. doi: 10.1016/j.bmc.2009.02.027. Epub 2009 Feb 21.
9
Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.围绕4-氧代-1,4-二氢喹啉-3-甲酰胺类进行的药物调制,一类强效CB2选择性大麻素受体配体:对受体亲和力和功能的影响。
J Med Chem. 2007 Nov 1;50(22):5471-84. doi: 10.1021/jm070387h. Epub 2007 Oct 4.
10
Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.作为CB1大麻素受体配体的哌嗪类似物的设计、合成及生物学评价
Bioorg Med Chem. 2008 Apr 1;16(7):4035-51. doi: 10.1016/j.bmc.2008.01.023. Epub 2008 Jan 19.

引用本文的文献

1
Synthesis and evaluation of novel thiohydantoin derivatives for antidiabetic activity using in silico in vitro and in vivo methods.利用计算机模拟、体外和体内方法合成并评估新型硫代乙内酰脲衍生物的抗糖尿病活性。
Sci Rep. 2025 Aug 1;15(1):28100. doi: 10.1038/s41598-025-13538-7.
2
Mechanism, kinetics and selectivity of selenocyclization of 5-alkenylhydantoins: an experimental and computational study.5-烯基乙内酰脲的硒环化反应机理、动力学及选择性:一项实验与计算研究
Beilstein J Org Chem. 2015 Oct 7;11:1865-75. doi: 10.3762/bjoc.11.200. eCollection 2015.
3
Optimization of biguanide derivatives as selective antitumor agents blocking adaptive stress responses in the tumor microenvironment.
优化双胍衍生物作为阻断肿瘤微环境中适应性应激反应的选择性抗肿瘤药物。
Drug Des Devel Ther. 2014 Jun 6;8:701-17. doi: 10.2147/DDDT.S59679. eCollection 2014.
4
In silico investigation of interactions between human cannabinoid receptor-1 and its antagonists.计算机模拟研究人类大麻素受体-1 与其拮抗剂的相互作用。
J Mol Model. 2012 Aug;18(8):3831-45. doi: 10.1007/s00894-012-1381-8. Epub 2012 Mar 9.
5
Evaluation of 2-thioxo-2,3,5,6,7,8-hexahydropyrimido[4,5-d]pyrimidin-4(1H)-one analogues as GAA activators.评估 2-硫代-2,3,5,6,7,8-六氢嘧啶并[4,5-d]嘧啶-4(1H)-酮类似物作为 GAA 激活剂。
Eur J Med Chem. 2010 May;45(5):1880-97. doi: 10.1016/j.ejmech.2010.01.027. Epub 2010 Feb 1.
6
Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716).大麻素CB(1)受体反向激动剂利莫那班(SR 141716)的突触前和外周效应。
Naunyn Schmiedebergs Arch Pharmacol. 2008 Oct;378(4):345-69. doi: 10.1007/s00210-008-0327-2. Epub 2008 Jul 25.
7
A simple synthesis of 2-thiohydantoins.2-硫代乙内酰脲的简易合成法。
Molecules. 2006 Oct 2;11(10):739-50. doi: 10.3390/11100739.